Catalyst Pharmaceutical CPRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $63.73M+12.3% | $52.7M-5.8% | $52.78M+20.3% | $52.11M+27.7% | $56.74M+144% | ||
| $70K-39.1% | $72K-36.8% | $72K-32.1% | $116K+27.5% | $115K+33.7% | ||
| $6.26M+7.0% | $5.66M+9.5% | $5.67M+28.2% | $7.6M+72.3% | $5.85M-29.1% | ||
| $59.59M-0.8% | $44.89M-36.7% | $32.44M-55.5% | $71.3M+11.2% | $60.04M+88.1% | ||
| $27K— | $32K-63.6% | $0-100% | $26K+160% | $0-100% | ||
| -$27K— | -$32K+63.6% | $0+100% | -$26K-160% | -$0+100% | ||
| $14.57M+130% | $6.33M— | $6.33M— | $6.33M— | $6.33M— | ||
| -$12.87M-521% | -$25.58M-677% | $4.65M— | $872K-24.6% | $3.06M-97.8% | ||
| $46.69M-26.0% | $19.28M-74.4% | $37.09M-44.3% | $72.14M+10.5% | $63.1M-63.5% | ||
| $59.56M-0.8% | $44.86M-36.6% | $32.44M-55.3% | $71.27M+11.1% | $60.04M+89.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Catalyst Pharmaceutical generate?
- Catalyst Pharmaceutical (CPRX) generated $208.2M in operating cash flow over the trailing twelve months.
- What is Catalyst Pharmaceutical's free cash flow?
- After $85.0K of capital expenditures, Catalyst Pharmaceutical's free cash flow was $208.1M over the trailing twelve months, down 22.2% year over year.
- Where does Catalyst Pharmaceutical's cash flow data come from?
- Every line is extracted from Catalyst Pharmaceutical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
